Page 172 - Simplicity is Key in CRT

172
References
1. Ponikowski, P., et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Devel- oped with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016.
2. Brignole, M., et al., 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardi- ac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J, 2013. 34(29): p. 2281-329.
3. Cleland, J.G., et al., An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resyn- chronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J, 2013. 34(46): p. 3547-56.
4. Woods, B., et al., Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart, 2015. 101(22): p. 1800-6.
5. Abraham, W.T., et al., Cardiac resynchronization in chronic heart failure. N Engl J Med, 2002. 346(24): p. 1845-53.
6. Cazeau, S., et al., Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction
delay. N Engl J Med, 2001. 344(12): p. 873-80.
7. Cleland, J.G., et al., The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005.
352(15): p. 1539-49.
8. Linde, C., et al., Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymp-
tomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol, 2008. 52(23): p.
1834-43.
9. Bristow, M.R., et al., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic
heart failure. N Engl J Med, 2004. 350(21): p. 2140-50.
10. Moss, A.J., et al., Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med, 2009.
361(14): p. 1329-38.
11. Tang, A.S., et al., Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med, 2010. 363(25): p.
2385-95.
12. Gold, M.R., et al., Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart
failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
Circulation, 2012. 126(7): p. 822-9.
13. Zareba, W., et al., Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the MultiCentre Automatic
Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation, 2011. 123(10): p. 1061-72.
14. Birnie, D.H., et al., Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail, 2013. 6(6): p. 1190-8.
15. Ruschitzka, F., et al., Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med, 2013.
369(15): p. 1395-405.
16. Eschalier, R., et al., Nonspecific intraventricular conduction delay: Definitions, prognosis, and implications for cardiac re-
synchronization therapy. Heart Rhythm, 2015. 12(5): p. 1071-9.
17. Goldstein, R.E., et al., Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of
MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling. Heart Rhythm, 2013.
10(3): p. 366-73.
18. van Deursen, C.J., et al., Vectorcardiographic QRS area as a novel predictor of response to cardiac resynchronization thera-
py. J Electrocardiol, 2015. 48(1): p. 45-52.
19. Engels, E.B., et al., T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch
block. J Cardiovasc Electrophysiol, 2015. 26(2): p. 176-83.
20. Mafi Rad, M., et al., Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by
electroanatomic mapping in candidates for cardiac resynchronization therapy. Heart Rhythm, 2016. 13(1): p. 217-25.
21. Maass, A.H., et al., Refining success of cardiac resynchronization therapy using a simple score predicting the amount of
reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study. Europace, 2017.
22. Epstein, A.E., et al., 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for de- vice-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2013. 61(3): p. e6-75.
23. European Heart Rhythm, A., et al., 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in
heart failure: implant and follow-up recommendations and management. Heart Rhythm, 2012. 9(9): p. 1524-76.